Within our intestines, trillions of microbes and products of our own body are involved in maintaining good health, and variations have been associated with an increasing number of diseases. We at BioMe Oxford Ltd are developing a small, ingestible gut-sampling device that will provide a reliable and cost-effective alternative to current sampling methods. The key advantage over existing technologies is that our product can sample any part of your intestines in a non-invasive manner, making it uniquely suitable for both research and diagnostic purposes. We are seeking investment to fund prototype development and safety studies in humans.
microbiome, gastrointestinal sampling, disease prediction, diagnostics